reported that PD-L1-expressing macrophages did not affect the interaction of effector T cells with tumor cells, and only act as “bystanders”; this may account for the lack of response to PD-1/PD-L1 blockade therapy in some patients with high PD-L1 expression (49). The gene discussed is PDCD1; the disease is neoplasm.